Altered Expression of FAS System Is Related to Adverse Clinical Outcome in Stage I-II Breast Cancer Patients Treated with Adjuvant Anthracycline-Based Chemotherapy

Claudio Botti, Marcella Mottolese, Maria Benevolo et al.|Clinical Cancer Research|2004

Cited by 40